Klivira
Request demo

Optimizing Urology Prior Authorization Automation for Enhanced Patient Access

Klivira's platform delivers comprehensive urology prior authorization automation, accelerating access to critical treatments and procedures for urology patients.

Revenue cycle directors and prior authorization coordinators in urology practices face unique challenges, from managing complex drug regimens for prostate cancer to navigating PA requirements for advanced surgical interventions. Manual workflows often lead to delays, denials, and administrative burden, impacting both financial health and patient outcomes. Klivira transforms these workflows through intelligent automation.

High-Volume Prior Authorization Triggers in Urology

Urology practices frequently encounter prior authorization requirements for high-cost medications, advanced imaging, and complex surgical procedures. These include androgen deprivation therapies (e.g., Lupron, Zoladex) and oral androgen-receptor inhibitors (e.g., Xtandi, Zytiga) for prostate cancer, as well as PSMA-targeted radiopharmaceuticals like Pluvicto. Minimally invasive BPH treatments such as UroLift, Rezum, and Aquablation, along with robotic urologic surgeries (e.g., prostatectomy, nephrectomy), also commonly trigger PA.

Key Documentation Requirements for Urologic PAs

  • **Prostate Cancer Treatments**: Gleason score, stage, PSA levels, prior treatment history, and NCCN-compendium-supported indications are frequently required by payers.
  • **BPH Treatments**: Documentation of symptom scores (IPSS), prostate size, and a trial of prior medical therapy are often necessary for coverage of procedures like UroLift or Aquablation.
  • **PSMA Imaging**: For advanced prostate cancer staging or biochemical recurrence, payers typically require documentation of PSA rise post-treatment, consistent with NCCN guidelines.
  • **Overactive Bladder (OAB) Treatments**: For medications like mirabegron (Myrbetriq) or onabotulinumtoxinA (Botox), and sacral neuromodulation (InterStim), evidence of failed conservative therapy or trial-phase results is critical.

Common Denial Reasons in Urology and Automation's Role

Urology PAs are frequently denied due to step therapy requirements for ED and OAB medications, medical-necessity gaps for advanced prostate cancer drugs lacking complete staging documentation, or NCD/LCD constraints for PSMA imaging. Additionally, insufficient duration of conservative therapy for BPH and OAB treatments often leads to denials. Klivira's automation proactively identifies these gaps and enforces payer-specific rules at the point of order entry, minimizing denials and streamlining the appeal process.

Streamlining Urology-Specific PA Workflows with Klivira

Klivira's platform addresses the unique workflow constraints of urology practices, including the urgency of prostate cancer treatment initiation and the high volume of specialty drug PAs. Our EMR integration, utilizing CDS Hooks for real-time detection at order entry, ensures that PA requirements for procedures like robotic prostatectomy or PSMA PET imaging are identified immediately. Klivira's policy engine is informed by AUA Clinical Practice Guidelines and NCCN for urologic oncology, ensuring documentation aligns with payer criteria.

Klivira's Automated Approach for Urologic Prior Authorizations

Klivira automates the end-to-end prior authorization workflow for urology, from initial order placement to approval write-back. Our system leverages Da Vinci CRD-style coverage requirement discovery and Da Vinci DTR for automated documentation assembly, pulling relevant FHIR resources from your EMR. Submissions are routed through optimal channels—Da Vinci PAS API, X12 278, or provider portal API—with intelligent fallback to fax. Real-time status tracking and automated denial routing, including appeal packet assembly, ensure timely resolution for critical urologic care.

Frequently asked questions

How does Klivira's automation handle urgent prior authorizations for prostate cancer treatments?

Klivira's EMR-side detection via CDS Hooks identifies PA requirements at order entry, preventing delays. For urgent cases like prostate cancer, our system prioritizes submissions and leverages real-time payer status polling, including adherence to CMS-0057-F expedited decision timeframes, to accelerate approvals and minimize treatment initiation delays.

Can Klivira integrate with our EMR to automate prior authorizations for urology orders?

Yes, Klivira offers robust EMR integration via SMART App Launch on FHIR for platforms like Epic, Cerner, and athenahealth, alongside HL7 v2 interfaces for legacy systems. This enables automated detection of urology orders that require PA, seamless documentation assembly, and direct write-back of authorization numbers to the patient's chart.

What specific urology treatments benefit most from Klivira's PA automation?

High-cost specialty drugs for prostate cancer (e.g., oral androgen-receptor inhibitors, radiopharmaceuticals), advanced imaging (e.g., PSMA PET, multiparametric prostate MRI), minimally invasive BPH procedures (e.g., UroLift, Aquablation), and robotic urologic surgeries are among the treatments that benefit significantly from Klivira's PA automation due to their complex documentation and high administrative burden.

How does Klivira address common denial reasons like step therapy for OAB medications?

Klivira's payer policy engine incorporates payer-specific step therapy rules for medications like those used in OAB. At the point of order, it can flag unmet step therapy requirements, guide the collection of necessary documentation, or facilitate automated appeals based on documented medical necessity, reducing preventable denials.

Does Klivira automate prior authorization for PSMA imaging for prostate cancer?

Yes, Klivira automates PA for PSMA imaging by integrating payer-specific NCD/LCD constraints and NCCN guidelines into its policy engine. It automatically pulls relevant clinical data, such as biochemical recurrence documentation, from the EMR to assemble the required packet and routes the request through the appropriate payer channel, including specific imaging-vendor routing if applicable.

Related coverage

Other urology prior auth workflows

Ready to automate this workflow for this specialty?

See how Klivira automates prior authorizations for your team.

Request a demo